Immunovant (NASDAQ:IMVT) Announces Earnings Results, Beats Estimates By $0.10 EPS
Immunovant (NASDAQ:IMVT - Get Free Report) issued its earnings results on Friday. The company reported ($0.61) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.71) by...